MACOM Technology Solutions announced a £45 million investment in UK‑based IQE plc, comprising equity and a convertible loan note, and secured long‑term supply agreements for epitaxial services that will support its GaN‑on‑SiC and other advanced process lines. The deal also grants MACOM a seat on IQE’s board of directors, giving the company a direct voice in the operations of a key supplier.
The investment and supply agreements are part of MACOM’s broader strategy to reduce supply‑chain risk as it expands capacity at its Research Triangle Park (RTP) fab. The company’s CEO, Stephen G. Daly, said, “IQE is an important supplier to MACOM. We believe this transaction will strengthen our supply chain resilience, while positioning IQE to improve its balance sheet and financial performance across its business.” The agreements are expected to improve yield, accelerate ramp‑up of new product lines, and maintain pricing power in high‑margin data‑center and defense segments.
MACOM’s Q1 FY2026 results provide context for the transaction. Revenue rose 24.5% year‑over‑year to $271.6 million, driven by strong demand in its data‑center, industrial‑and‑defense, and telecom segments. Adjusted earnings per share of $1.02 beat analyst expectations of $0.9973, a $0.0227 or 2.3% beat, largely due to cost controls and a favorable product mix that shifted toward higher‑margin GaN and photonic subassemblies. Adjusted gross margin expanded to 57.6% from 57.5% in the prior year, reflecting pricing power and operational leverage as revenue scales.
The company reiterated its guidance for the data‑center segment, targeting 35%–40% year‑over‑year revenue growth, and reaffirmed its confidence in the 800 G/1.6 T optical interconnect market. Daly noted, “We are gaining confidence that our Data Center revenue could achieve 35% to 40% year‑over‑year growth. Hyperscalers’ capital investments are robust, which is driving demand for our 800 and 1.6T optical and high‑speed analog products.” MACOM also highlighted that its cash and short‑term investments totaled approximately $768 million at quarter‑end, providing a strong balance‑sheet foundation for the investment in IQE.
The long‑term supply agreements and equity stake position MACOM to secure a reliable source of high‑quality epitaxial wafers, reduce exposure to global supply‑chain disruptions, and accelerate the ramp‑up of its advanced GaN‑on‑SiC and optical product lines. The transaction aligns with MACOM’s goal of reaching a 60% gross margin by FY27 and supports its broader strategy to scale production in high‑growth data‑center and defense markets.
The deal also signals MACOM’s commitment to domestic manufacturing, as the company has assumed full operational control of its RTP fab ahead of schedule. With the new supply agreements in place, MACOM can better manage capacity, improve yield, and maintain pricing power in its high‑margin segments, reinforcing its competitive position in the semiconductor industry.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.